CERS cerus.com: Nilai perusahaan marang pendapatan

Simbol resmi perusahaan Cerus (CERS)

The current EV/Sales value demonstrates that the asset is overheated, while the 1775.26 metric indicates a high risk of write-down. Optimized consumables logistics for Cerus Corporation (CERS) eliminate supply disruptions. Leadership in pathogen reduction via INTERCEPT establishes the company as a global safety standard. The production of blood inactivation systems guarantees steady sales to hospitals, minimizing medical risks.

cerus.com (CERS): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

CERS (Cerus Inc): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
- data saldo dhuwit lan arus kas:
Pambiji fundamental perusahaan:Cerus Corporation
Produk sing diprodhuksi Cerus Corp

The EV/Sales ratio determines the value of a business, including debt and excluding cash, relative to annual revenue. This metric measures the market valuation of one dollar of revenue, neutralizing the impact of capital structure. By analyzing EV/Sales trends, an investor can identify abnormal consolidation prior to volatility spikes. For Cerus Corporation (CERS), this reflects the dependence of capitalization on the adoption rates of blood purification systems. The expansion of technology authorizations directly adjusts the company's fundamental value.

Analisis pesaing Cerus Corporation

ISRG - Multiplikator EV/Sales|DHR: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan BD (BDX)|Rasio nilai perusahaan marang pendapatan STERIS plc|Rasio nilai perusahaan marang pendapatan WST (West Pharmaceutical Services)|Nilai perusahaan marang pendapatan BAX (Baxter Corp)|Masimo - Rasio nilai perusahaan marang pendapatan|Stevanato Group S.p.A. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Teleflex Inc (TFX)|MMSI - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Envista Holdings Corp NVST|ICUI: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XRAY|LMAT (LeMaitre Corp) - Multiplikator EV/Sales|ATRC (AtriCure Inc) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales STAA|NAGE (ChromaDex Corp) - Nilai bisnis marang pendapatan|ZimVie Inc. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan angiodynamics.com (ANGO)|teknova.com - Multiplikator EV/Sales|Rasio nilai perusahaan marang dodolan Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan KORU Medical Systems KRMD|Rasio nilai perusahaan marang pendapatan Nyxoah SA (NYXH)|Koefisien nilai perusahaan marang pendapatan MBOT|Multiplikator EV/Sales PDEX (Pro-Dex Inc.)|Koefisien nilai perusahaan marang pendapatan ZTEK (Zentek Limited)|elutia.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Nilai perusahaan marang pendapatan|Retractable Technologies - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan harvardbioscience.com|Femasys Corp (FEMY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales MHUA|Predictive Oncology Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales CJMB (Callan JMB Inc)|Multiplikator EV/Sales Atrion Corp ATRI|NeuroMetrix Corporation - Multiplikator EV/Sales